{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:13:21Z","timestamp":1728620001477},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,9]]},"DOI":"10.7759\/cureus.71173","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:55:21Z","timestamp":1728539721000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Challenges in Nephrotic Syndrome Presenting With Venous Thromboembolism"],"prefix":"10.7759","author":[{"given":"Abhinav R","family":"Thummala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Morad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily E","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13002","article-title":"The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies","volume":"205","author":"Atwell TD","year":"2015","unstructured":"Atwell TD, Spanbauer JC, McMenomy BP, et al.. The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. AJR Am J Roentgenol. 2015, 205:190-5. 10.2214\/AJR.14.13002","journal-title":"AJR Am J Roentgenol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.274","article-title":"Thrombosis and hemostasis in renal disease","volume":"46","author":"Rabelink TJ","year":"1994","unstructured":"Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994, 46:287-96. 10.1038\/ki.1994.274","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin BA","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012, 7:513-20. 10.2215\/CJN.10131011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi BK","year":"2008","unstructured":"Mahmoodi BK, ten Kate MK, Waanders F, et al.. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008, 117:224-30. 10.1161\/CIRCULATIONAHA.107.716951","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw227","article-title":"Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome","volume":"32","author":"Gyamlani G","year":"2017","unstructured":"Gyamlani G, Molnar MZ, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017, 32:157-64. 10.1093\/ndt\/gfw227","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102162","article-title":"Thromboembolism in nephrotic syndrome: controversies and uncertainties","volume":"7","author":"Parker K","year":"2023","unstructured":"Parker K, Ragy O, Hamilton P, Thachil J, Kanigicherla D. Thromboembolism in nephrotic syndrome: controversies and uncertainties. Res Pract Thromb Haemost. 2023, 7:102162. 10.1016\/j.rpth.2023.102162","journal-title":"Res Pract Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02929-x","article-title":"Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases","volume":"23","author":"Kelddal S","year":"2022","unstructured":"Kelddal S, Hvas AM, Grove EL, Birn H. Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases. BMC Nephrol. 2022, 23:305. 10.1186\/s12882-022-02929-x","journal-title":"BMC Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.09.011","article-title":"Pharmacokinetics and pharmacodynamics of apixaban in nephrotic syndrome: findings from a phase 1a trial","volume":"81","author":"Derebail VK","year":"2023","unstructured":"Derebail VK, Zhu J, Crawford ML, et al.. Pharmacokinetics and pharmacodynamics of apixaban in nephrotic syndrome: findings from a phase 1a trial. Am J Kidney Dis. 2023, 81:373-6. 10.1053\/j.ajkd.2022.09.011","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.02.010","article-title":"Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome","volume":"3","author":"Sexton DJ","year":"2018","unstructured":"Sexton DJ, de Freitas DG, Little MA, McHugh T, Magee C, Conlon PJ, O'Seaghdha CM. Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome. Kidney Int Rep. 2018, 3:784-93. 10.1016\/j.ekir.2018.02.010","journal-title":"Kidney Int Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255009","article-title":"Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study","volume":"16","author":"Welander F","year":"2021","unstructured":"Welander F, Holmberg H, Dim\u00e9ny E, Jansson U, Sj\u00e4lander A. Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study. PLoS One. 2021, 16:0255009. 10.1371\/journal.pone.0255009","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/10600280221129348","article-title":"Direct oral anticoagulants versus Warfarin for venous thromboembolism prophylaxis in patients with nephrotic syndrome: a retrospective cohort study","volume":"57","author":"Tijani A","year":"2023","unstructured":"Tijani A, Coons EM, Mizuki B, et al.. Direct oral anticoagulants versus Warfarin for venous thromboembolism prophylaxis in patients with nephrotic syndrome: a retrospective cohort study. Ann Pharmacother. 2023, 57:787-94. 10.1177\/10600280221129348","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000362162","article-title":"Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran","volume":"4","author":"Sasaki Y","year":"2014","unstructured":"Sasaki Y, Raita Y, Uehara G, Higa Y, Miyasato H. Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran. Case Rep Nephrol Urol. 2014, 4:42-52. 10.1159\/000362162","journal-title":"Case Rep Nephrol Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8742-16","article-title":"Edoxaban was effective for treating renal vein thrombosis in a patient with nephrotic syndrome","volume":"56","author":"Shimada Y","year":"2017","unstructured":"Shimada Y, Nagaba Y, Nagaba H, et al.. Edoxaban was effective for treating renal vein thrombosis in a patient with nephrotic syndrome. Intern Med. 2017, 56:2307-10. 10.2169\/internalmedicine.8742-16","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014549349","article-title":"Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability","volume":"48","author":"Dupree LH","year":"2014","unstructured":"Dupree LH, Reddy P. Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability. Ann Pharmacother. 2014, 48:1655-8. 10.1177\/1060028014549349","journal-title":"Ann Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016585","article-title":"Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: a case report","volume":"98","author":"Li Y","year":"2019","unstructured":"Li Y, Chen Y, Qi X, Hu B, Du Q, Qian Y. Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: a case report. Medicine (Baltimore). 2019, 98:16585. 10.1097\/MD.0000000000016585","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0552-9","article-title":"Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy","volume":"32","author":"Reynolds ML","year":"2019","unstructured":"Reynolds ML, Nachman PH, Mooberry MJ, Crona DJ, Derebail VK. Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy. J Nephrol. 2019, 32:669-72. 10.1007\/s40620-018-0552-9","journal-title":"J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688422","article-title":"Complications of percutaneous renal biopsy","volume":"36","author":"Bakdash K","year":"2019","unstructured":"Bakdash K, Schramm KM, Annam A, Brown M, Kondo K, Lindquist JD. Complications of percutaneous renal biopsy. Semin Intervent Radiol. 2019, 36:97-103. 10.1055\/s-0039-1688422","journal-title":"Semin Intervent Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997","volume":"30","author":"Haas M","year":"1997","unstructured":"Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997, 30:621. 10.1016\/S0272-6386(97)90485-6","journal-title":"Am J Kidney Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli M","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017, 12:332-45. 10.2215\/CJN.05000516","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01920219","article-title":"Management of adult minimal change disease","volume":"14","author":"Korbet SM","year":"2019","unstructured":"Korbet SM, Whittier WL. Management of adult minimal change disease. Clin J Am Soc Nephrol. 2019, 14:911-3. 10.2215\/CJN.01920219","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy","volume":"11","author":"Mak SK","year":"1996","unstructured":"Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant. 1996, 11:2192-201. 10.1093\/oxfordjournals.ndt.a027136","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019050546","article-title":"Comparison of the efficacy and safety of tacrolimus and low-dose corticosteroid with high-dose corticosteroid for minimal change nephrotic syndrome in adults","volume":"32","author":"Chin HJ","year":"2021","unstructured":"Chin HJ, Chae DW, Kim YC, et al.. Comparison of the efficacy and safety of tacrolimus and low-dose corticosteroid with high-dose corticosteroid for minimal change nephrotic syndrome in adults. J Am Soc Nephrol. 2021, 32:199-210. 10.1681\/ASN.2019050546","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm637","article-title":"Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome","volume":"23","author":"Li X","year":"2008","unstructured":"Li X, Li H, Chen J, et al.. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol Dial Transplant. 2008, 23:1919-25. 10.1093\/ndt\/gfm637","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289843-diagnostic-challenges-in-nephrotic-syndrome-presenting-with-venous-thromboembolism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:55:23Z","timestamp":1728539723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289843-diagnostic-challenges-in-nephrotic-syndrome-presenting-with-venous-thromboembolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.71173","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}